Clinical Trials in Los Angeles

Showing 10781-10800 of 14,465 trials

Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth

NCT00106964

Hepatitis B is a contagious virus that can damage a person's liver. It can be prevented by vaccination, but for many HIV-positive people, the vaccines do not help them achieve adequate protection against this virus. In an attempt to improve response to vaccination and achieve protection from hepatitis B, this trial will compare the immune system response to 3 hepatitis B vaccine regimens in HIV-positive adolescents 12 through 24 years of age.

HIV InfectionHepatitis B

University of North Carolina, Chapel Hill371 participantsStarted Jan 2004

Los Angeles, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +8 more locations

COMPLETEDNA< 1 mile

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

NCT00491556

This study proposes to evaluate a pre-DHHS guideline of HAART initiation and then de-intensification management strategy in adolescents with mild immunosuppression and compare changes in CD4% from baseline to week 48 and then during de-intensification.

HIV Infections

University of North Carolina, Chapel Hill102 participantsStarted Oct 2007

Los Angeles, California, United States • Los Angeles, California, United States • San Francisco, California, United States +20 more locations

Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

Find Trials by Condition in Los Angeles

Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles

Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)

Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Study In People With Type 2 Diabetes

Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry

Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease

Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis

An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease

Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients

High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam)

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital

Effectiveness of Arginine as a Treatment for Sickle Cell Anemia

Post-Approval Study to Investigate the Long Term (8 Year) Survivorship of STAR Ankle Among Continued Access Study Patients

Improving Care and Reducing Cost Study

Caffeine as a Therapy for Parkinson's Disease